Resorbable (Bioresorbable) Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Agro-Polymers, Biopolyesters, Others), By Application (Orthopedics, Cardiac Implants, Dental Implants, Oral Drug Delivery, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 483.43 MIllion
CAGR (2026-2031)	4.91%
Fastest Growing Segment	Orthopedics
Largest Market	North America
Market Size (2031)	USD 644.52 MIllion

Market Overview

The Global Resorbable (Bioresorbable) Polymers Market will grow from USD 483.43 MIllion in 2025 to USD 644.52 MIllion by 2031 at a 4.91% CAGR. Resorbable polymers are a specialized class of biodegradable materials engineered to degrade safely within the human body, thereby eliminating the need for secondary surgical removal after tissue repair. The primary drivers fueling market expansion include the rising prevalence of chronic conditions among an aging global population and the increasing preference for minimally invasive medical procedures. These materials are essential in orthopedic fixation devices and controlled drug delivery systems, where their ability to provide temporary support before being metabolized offers a distinct clinical advantage over permanent metal implants.

Despite this robust demand, the sector encounters a significant challenge regarding the rigorous and costly regulatory pathway required for medical-grade certification. Manufacturers must navigate complex compliance standards that can delay product commercialization. According to European Bioplastics, in 2024, the global production capacity for bioplastics, which encompasses key resorbable materials such as polylactic acid, reached approximately 2.47 million tonnes. While this indicates a strengthening supply chain, the stringent requirements for clinical validation continue to impede the speed at which new polymer innovations can enter the medical market.

Key Market Drivers

The elimination of secondary surgical procedures for implant removal and the subsequent shift from metallic to bioresorbable medical implants are fundamentally reshaping the market. These polymers degrade harmlessly within the body, removing the clinical risks and healthcare costs associated with follow-up extraction surgeries common with titanium or steel hardware. This clinical advantage is driving substantial adoption in orthopedic fixation and sports medicine, where temporary support is sufficient for bone healing. According to Corbion, March 2024, in the 'Annual Report 2023', the biomedical polymers business continued its double-digit growth trajectory, validating the accelerating industrial demand for resorbable materials in trauma management and controlled release applications.

Technological innovations in 3D bioprinting and scaffolding are further propelling market expansion by enabling the fabrication of highly customized, patient-specific tissue constructs. Advanced additive manufacturing allows for the creation of porous resorbable structures that mimic natural soft tissue, fostering regeneration before metabolizing. According to BellaSeno, August 2024, in a press statement regarding its clinical program, 41 patients have been successfully treated with the company’s 3D-printed resorbable scaffolds, demonstrating the safety and viability of these next-generation implants. The broader industrial environment supports this scalability; according to the Plastics Industry Association, in 2024, the North American region alone was estimated to account for 18.7% of the global bioplastics production capacity, ensuring a robust material supply chain for these expanding medical technologies.

Download Free Sample Report

Key Market Challenges

The stringent and costly regulatory pathway for medical-grade certification represents a substantial impediment to the growth of the Global Resorbable (Bioresorbable) Polymers Market. Manufacturers face an increasingly complex compliance landscape, particularly under heightened frameworks which demand extensive clinical data and technical documentation. This environment significantly increases the financial burden and time-to-market for new polymer-based devices, directly stifling innovation and deterring market entry for smaller enterprises that lack the resources to navigate these protracted procedures.

The impact of these heightened standards is quantifiable and severe. According to MedTech Europe, in 2024, certification and maintenance costs under the Medical Device Regulation escalated by up to 100% compared to previous directives. Such extensive delays and soaring costs compel companies to divert capital away from research and development toward compliance activities. Consequently, the introduction of advanced resorbable polymer technologies is slowed, limiting their commercial availability and restraining the overall market momentum despite the underlying clinical demand for these materials.

Key Market Trends

The adoption of bioresorbable polymers in sustainable packaging is accelerating as the market diversifies beyond medical applications to address global circular economy mandates. Unlike the low-volume, high-margin medical sector, this trend is characterized by a massive industrial scale-up of materials like polylactic acid (PLA) to replace fossil-based plastics in single-use items. Major producers are securing substantial capital to expand manufacturing capabilities, validating the shift toward compostable solutions that reduce environmental persistence. According to NatureWorks, May 2024, in the press release 'Ingeo PLA Manufacturing Expansion Attracts Record Financing', the company secured a 12.6 billion THB syndicated loan to fund the construction of its new fully integrated biopolymer manufacturing complex in Thailand, ensuring a robust supply for these non-medical applications.

The expansion of electrospun nanofibers for advanced wound care represents a critical technical evolution, utilizing high-surface-area matrices to actively modulate the healing environment. Distinct from the structural support provided by 3D-printed orthopedic implants, these nanofibrous dressings are designed for the topical management of burns and ulcers, offering capabilities such as exudate absorption and infection control through precise pH regulation. This technology enables the creation of bioengineered synthetic matrices that accelerate closure rates by optimizing the wound bed's acidity. According to Medical Product Outsourcing, October 2024, in the article 'Royal Wound-X Launches Two New Wound Healing Technologies', the company's new ElectroFiber 3D scaffold demonstrated the ability to reduce wound pH from 7.4 to 5.9 within 78 hours, significantly hindering bacterial growth while promoting tissue regeneration.

Segmental Insights

The Orthopedics segment stands out as the fastest-growing category within the Global Resorbable Polymers Market due to the rising adoption of materials that eliminate the need for secondary removal surgeries. Unlike permanent metallic implants, bioresorbable fixation devices naturally degrade within the body, offering significant clinical advantages such as reduced patient trauma and lower hospitalization costs. This shift is further supported by the increasing approval of advanced polymer-based bone fixation products by regulatory entities like the U.S. Food and Drug Administration. Consequently, the preference for absorbable sutures, screws, and pins continues to drive substantial expansion in this sector.

Regional Insights

Based on insights from trusted market research, North America leads the Global Resorbable (Bioresorbable) Polymers Market due to its advanced healthcare infrastructure and the high volume of surgical interventions performed annually. The region benefits from a robust ecosystem of medical device manufacturers that actively incorporate these materials into orthopedic and dental implants to eliminate the need for secondary removal surgeries. Furthermore, the United States Food and Drug Administration (FDA) supports this growth through clear regulatory pathways that facilitate the approval of safe, innovative medical technologies. This combination of strong industrial capability and a favorable regulatory environment cements North America’s position as the dominant market globally.

Recent Developments

• In September 2025, REVA Medical announced positive 36-month results from a clinical trial evaluating its MOTIV Bioresorbable Scaffold for the treatment of below-the-knee artery disease. The study data confirmed the long-term safety and efficacy of the device, which is manufactured from a proprietary polymer designed to provide structural support before naturally dissolving in the body. These findings validated the performance of the scaffold in maintaining vessel patency without leaving a permanent metallic implant behind. This development represented a significant breakthrough in the Global Resorbable (Bioresorbable) Polymers Market, demonstrating the clinical viability of resorbable technologies for complex peripheral vascular interventions.
• In January 2025, GEON Performance Solutions announced its acquisition of Foster Corporation, a prominent specialist in the compounding of biomedical polymers for the healthcare industry. This strategic transaction was executed to strengthen the acquiring company's capabilities in the high-growth medical market, specifically adding expertise in bioresorbable polymers and other implantable materials. Foster Corporation is recognized for its ability to formulate custom polymer compounds that degrade safely within the body, a critical requirement for temporary medical devices. The integration of these assets provided the new parent company with advanced clean-room manufacturing facilities and deep technical know-how, significantly expanding its offering in the Global Resorbable (Bioresorbable) Polymers Market.
• In April 2024, Evonik expanded its production capacity for RESOMER powder biomaterials at its site in Darmstadt, Germany, to address rising demand in the Global Resorbable (Bioresorbable) Polymers Market. The company introduced an advanced solvent-free micronization technology that allows for the production of high-precision powders with customizable particle sizes and material properties. This investment was specifically targeted at supporting applications in 3D-printed medical implants and aesthetic procedures, where precise degradation rates are essential. By enhancing its manufacturing infrastructure, the company aimed to provide medical device developers with a broader range of standard and custom bioresorbable polymer grades produced under strict quality standards.
• In February 2024, DSM Biomedical, a subsidiary of dsm-firmenich, announced a significant investment to expand its manufacturing footprint with a new facility in Exton, Pennsylvania. This expansion was driven by the rapid growth of the company's portfolio, which includes advanced bioresorbable polymers and natural materials used in surgical and therapeutic devices. The new infrastructure was designed to support the company's strategy of offering specialized manufacturing services to medical technology partners, thereby facilitating the development of next-generation implantable devices. This move reinforced the company's position as a key supplier in the Global Resorbable (Bioresorbable) Polymers Market, ensuring a reliable supply of critical biomaterials for patient care.

Key Market Players

• Corbion NV
• Poly-Med, Inc.
• Foster Corporation
• Evonik Industries AG
• KLS-Martin Limited
• 3d Biotek LLC
• Degradable solutions AG
• Koninklijke DSM N.V.
• FUTERRO S.A.
• Abbott Laboratories Inc

By Type	By Application	By Region
Agro-Polymers Biopolyesters Others	Orthopedics Cardiac Implants Dental Implants Oral Drug Delivery Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Resorbable (Bioresorbable) Polymers Market , By Type:

• Agro-Polymers
• Biopolyesters
• Others

• Resorbable (Bioresorbable) Polymers Market , By Application:

• Orthopedics
• Cardiac Implants
• Dental Implants
• Oral Drug Delivery
• Others

• Resorbable (Bioresorbable) Polymers Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE